BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19293188)

  • 21. Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53.
    Chen J; Huang X; Halicka D; Brodsky S; Avram A; Eskander J; Bloomgarden NA; Darzynkiewicz Z; Goligorsky MS
    Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1575-86. PubMed ID: 16243918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells.
    Xia TS; Shi JP; Ding Q; Liu XA; Zhao Y; Liu YX; Xia JG; Wang S; Ding YB
    Med Oncol; 2012 Jun; 29(2):448-53. PubMed ID: 21347717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
    Gray-Schopfer VC; Cheong SC; Chong H; Chow J; Moss T; Abdel-Malek ZA; Marais R; Wynford-Thomas D; Bennett DC
    Br J Cancer; 2006 Aug; 95(4):496-505. PubMed ID: 16880792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
    Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
    Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype.
    Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW
    Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.
    Abel EV; Aplin AE
    Cancer Res; 2010 Apr; 70(7):2891-900. PubMed ID: 20332228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cells.
    Jackson TR; Salmina K; Huna A; Inashkina I; Jankevics E; Riekstina U; Kalnina Z; Ivanov A; Townsend PA; Cragg MS; Erenpreisa J
    Cell Cycle; 2013 Feb; 12(3):430-41. PubMed ID: 23287532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.
    Shin SH; Lee KH; Kim BH; Lee S; Lee HS; Jang JJ; Kang GH
    Lab Invest; 2014 Dec; 94(12):1396-405. PubMed ID: 25310533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
    Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
    Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 'synthetic-sickness' screen for senescence re-engagement targets in mutant cancer backgrounds.
    Cairney CJ; Godwin LS; Bilsland AE; Burns S; Stevenson KH; McGarry L; Revie J; Moore JD; Wiggins CM; Collinson RS; Mudd C; Tsonou E; Sadaie M; Bennett DC; Narita M; Torrance CJ; Keith WN
    PLoS Genet; 2017 Aug; 13(8):e1006942. PubMed ID: 28806777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation.
    Rigby S; Huang Y; Streubel B; Chott A; Du MQ; Turner SD; Bacon CM
    J Biol Chem; 2009 Sep; 284(39):26871-81. PubMed ID: 19535334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and methylation status of the Syk gene in cervical carcinoma.
    Zhao S; Sun G; Tony PW; Ma D; Zhao C
    Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BS69 is involved in cellular senescence through the p53-p21Cip1 pathway.
    Zhang W; Chan HM; Gao Y; Poon R; Wu Z
    EMBO Rep; 2007 Oct; 8(10):952-8. PubMed ID: 17721438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway.
    Wang G; Fu Y; Hu F; Lan J; Xu F; Yang X; Luo X; Wang J; Hu J
    Cell Death Dis; 2017 Feb; 8(2):e2607. PubMed ID: 28182012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
    Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
    Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of spleen tyrosine kinase expression re-activation by inhibition of DNA methylation on oncogenesis growth of gastric cancer].
    Ding YB; Xia JG; Chen GY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):523-6. PubMed ID: 17143801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway.
    Binet R; Ythier D; Robles AI; Collado M; Larrieu D; Fonti C; Brambilla E; Brambilla C; Serrano M; Harris CC; Pedeux R
    Cancer Res; 2009 Dec; 69(24):9183-91. PubMed ID: 19951988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
    Wang L; Devarajan E; He J; Reddy SP; Dai JL
    Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PPARĪ³-SETD8 axis constitutes an epigenetic, p53-independent checkpoint on p21-mediated cellular senescence.
    Shih CT; Chang YF; Chen YT; Ma CP; Chen HW; Yang CC; Lu JC; Tsai YS; Chen HC; Tan BC
    Aging Cell; 2017 Aug; 16(4):797-813. PubMed ID: 28514051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer.
    Dong SW; Ma L; Xu N; Yan HQ; Liu HY; Li YW; Zhang P
    Neoplasma; 2011; 58(1):89-95. PubMed ID: 21067271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.